TY  - JOUR

T1  - Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

JO  - The Lancet Global Health

PY  - 2014/01/01

AU  - Eaton JW

AU  - Menzies NA

AU  - Stover J

AU  - Cambiano V

AU  - Chindelevitch L

AU  - Cori A

AU  - Hontelez JAC

AU  - Humair S

AU  - Kerr CC

AU  - Klein DJ

AU  - others

ED  - 

DO  - DOI: 10.1016/S2214-109X(13)70172-4

PB  - Elsevier

VL  - 2

IS  - 1

SP  - e23

EP  - e34

Y2  - 2024/12/22

ER  -